BioBlast Pharma Ltd, a clinical stage biotechnology company focusing on therapies for rare genetic diseases, is celebrating its recent IPO and the end of its quiet period with a visit to the NASDAQ MarketSite in Times Square. CEO Dr. Dalia ...

Read More »